[{"data":1,"prerenderedAt":989},["ShallowReactive",2],{"report:en:business-development":3},{"schemaVersion":4,"locale":5,"direction":6,"routeId":7,"slug":8,"title":9,"source":10,"sourceSections":14},"1.0.0","en","ltr","business-development","strategy\u002Fbusiness-development","Business Development",{"authority":11,"documentName":12,"sha256":13},"official-locale-idml","افالون فارما - التقرير السنوي english 2025 v3.20.indd","297bf7518216874132615aafd4aa637a92908ea1b50f6ee659ee25b8a368e0ea",[15],{"id":7,"title":16,"preview":17,"stories":20},"03 Business Development",[18,19],"Avalon Pharma operates a network of advanced facilities, each designed to meet the needs of healthcare:","Avalon Pharma 1 Focuses on the production of tablets and capsules, nasal sprays, creams, topical solutions, and cosmetic products.",[21,71,115,143,170,190,210,249,292,322,357,391,587,646,678,711,735,766,879],{"id":22,"direction":23,"blocks":24},"uc6cf","RightToLeftDirection",[25,56],{"id":26,"type":27,"text":28,"paragraphStyle":29,"runs":32},"uc6cf:p0001","paragraph","Specialized Manufacturing Facilities\n",{"id":30,"name":31},"ParagraphStyle\u002Fmain text group%3amain text med blue -mah","main text group:main text med blue -mah",[33,49],{"character_style":34,"text":37,"token_types":38,"overrides":40,"properties":43},{"id":35,"name":36},"CharacterStyle\u002F$ID\u002F[No character style]","[No character style]","Specialized Manufacturing Facilities",[39],"content",{"FontStyle":41,"PointSize":42},"Bold","12",[44],{"tag":45,"attributes":46,"text":48},"Leading",{"type":47},"enumeration","Auto",{"character_style":50,"text":51,"token_types":52,"overrides":54,"properties":55},{"id":35,"name":36},"\n",[53],"line_break",{"PointSize":42},[],{"id":57,"type":27,"text":18,"paragraphStyle":58,"runs":61},"uc6cf:p0002",{"id":59,"name":60},"ParagraphStyle\u002Fmain text","main text",[62],{"character_style":63,"text":18,"token_types":64,"overrides":65,"properties":66},{"id":35,"name":36},[39],{},[67],{"tag":45,"attributes":68,"text":70},{"type":69},"unit","16",{"id":72,"direction":23,"blocks":73},"ud2df",[74],{"id":75,"type":27,"text":76,"paragraphStyle":77,"runs":80},"ud2df:p0001","Avalon Pharma 1\nFocuses on the production of tablets and capsules, nasal sprays, creams, topical solutions, and cosmetic products.\n",{"id":78,"name":79},"ParagraphStyle\u002Fmain text ww","main text ww",[81,88,94,99,107],{"character_style":82,"text":83,"token_types":84,"overrides":85,"properties":87},{"id":35,"name":36},"Avalon Pharma ",[39],{"FontStyle":41,"PointSize":86},"15",[],{"character_style":89,"text":90,"token_types":91,"overrides":92,"properties":93},{"id":35,"name":36},"1",[39],{"FontStyle":41,"PointSize":86},[],{"character_style":95,"text":51,"token_types":96,"overrides":97,"properties":98},{"id":35,"name":36},[53],{"FontStyle":41},[],{"character_style":100,"text":101,"token_types":102,"overrides":103,"properties":104},{"id":35,"name":36},"Focuses on the production of tablets and capsules, nasal sprays, creams, topical solutions, and cosmetic products",[39],{},[105],{"tag":45,"attributes":106,"text":48},{"type":47},{"character_style":108,"text":109,"token_types":110,"overrides":111,"properties":112},{"id":35,"name":36},".\n",[39,53],{"FontStyle":41},[113],{"tag":45,"attributes":114,"text":48},{"type":47},{"id":116,"direction":23,"blocks":117},"ud2c4",[118],{"id":119,"type":27,"text":120,"paragraphStyle":121,"runs":122},"ud2c4:p0001","Avalon Pharma 2 initially operated as a comprehensive R&D center and analytical development laboratory. Later, solid dosage production lines were added with an annual capacity of 272 million tablets, alongside semi-solid preparations with an annual capacity of 22 million units.",{"id":78,"name":79},[123,129,135],{"character_style":124,"text":125,"token_types":126,"overrides":127,"properties":128},{"id":35,"name":36},"Avalon Pharma 2",[39],{"FontStyle":41,"PointSize":86},[],{"character_style":130,"text":131,"token_types":132,"overrides":133,"properties":134},{"id":35,"name":36}," ",[39],{"PointSize":86},[],{"character_style":136,"text":137,"token_types":138,"overrides":139,"properties":140},{"id":35,"name":36},"initially operated as a comprehensive R&D center and analytical development laboratory. Later, solid dosage production lines were added with an annual capacity of 272 million tablets, alongside semi-solid preparations with an annual capacity of 22 million units.",[39],{},[141],{"tag":45,"attributes":142,"text":48},{"type":47},{"id":144,"direction":23,"blocks":145},"ua551",[146],{"id":147,"type":27,"text":148,"paragraphStyle":149,"runs":150},"ua551:p0001","22\nMillion Units",{"id":78,"name":79},[151,164],{"character_style":152,"text":153,"token_types":154,"overrides":155,"properties":158},{"id":35,"name":36},"22",[39],{"FillColor":156,"FontStyle":41,"PointSize":157},"Color\u002Fprimary","50",[159],{"tag":160,"attributes":161,"text":163},"AppliedFont",{"type":162},"string","Helvetica",{"character_style":165,"text":166,"token_types":167,"overrides":168,"properties":169},{"id":35,"name":36},"\nMillion Units",[53,39],{},[],{"id":171,"direction":23,"blocks":172},"ud2a9",[173],{"id":174,"type":27,"text":175,"paragraphStyle":176,"runs":177},"ud2a9:p0001","Avalon Pharma 3 is the largest disinfectant manufacturer in Saudi Arabia, also producing sanitizers, mouthwashes, external-use liquids, and large-size hygiene products.",{"id":78,"name":79},[178,184],{"character_style":179,"text":180,"token_types":181,"overrides":182,"properties":183},{"id":35,"name":36},"Avalon Pharma 3",[39],{"FontStyle":41,"PointSize":86},[],{"character_style":185,"text":186,"token_types":187,"overrides":188,"properties":189},{"id":35,"name":36}," is the largest disinfectant manufacturer in Saudi Arabia, also producing sanitizers, mouthwashes, external-use liquids, and large-size hygiene products.",[39],{},[],{"id":191,"direction":23,"blocks":192},"ud28f",[193],{"id":194,"type":27,"text":195,"paragraphStyle":196,"runs":197},"ud28f:p0001","Avalon Pharma 4 is a future-ready facility designed to manufacture injectable products, oncology drugs, and ophthalmic preparations, enhancing Avalon’s capabilities in specialized healthcare solutions.",{"id":78,"name":79},[198,204],{"character_style":199,"text":200,"token_types":201,"overrides":202,"properties":203},{"id":35,"name":36},"Avalon Pharma 4",[39],{"FontStyle":41,"PointSize":86},[],{"character_style":205,"text":206,"token_types":207,"overrides":208,"properties":209},{"id":35,"name":36}," is a future-ready facility designed to manufacture injectable products, oncology drugs, and ophthalmic preparations, enhancing Avalon’s capabilities in specialized healthcare solutions.",[39],{},[],{"id":211,"direction":23,"blocks":212},"uc6b4",[213,231],{"id":214,"type":27,"text":215,"paragraphStyle":216,"runs":217},"uc6b4:p0001","Commitment to Sustainability and Compliance\n",{"id":30,"name":31},[218,226],{"character_style":219,"text":220,"token_types":221,"overrides":222,"properties":223},{"id":35,"name":36},"Commitment to Sustainability and Compliance",[39],{"FontStyle":41,"PointSize":42},[224],{"tag":45,"attributes":225,"text":48},{"type":47},{"character_style":227,"text":51,"token_types":228,"overrides":229,"properties":230},{"id":35,"name":36},[53],{},[],{"id":232,"type":27,"text":233,"paragraphStyle":234,"runs":235},"uc6b4:p0002","Avalon Pharma maintains strict environmental and regulatory standards, reinforcing its commitment to responsible manufacturing through: \n",{"id":59,"name":60},[236,244],{"character_style":237,"text":238,"token_types":239,"overrides":240,"properties":241},{"id":35,"name":36},"Avalon Pharma maintains strict environmental and regulatory standards, reinforcing its commitment to responsible manufacturing through: ",[39],{},[242],{"tag":45,"attributes":243,"text":48},{"type":47},{"character_style":245,"text":51,"token_types":246,"overrides":247,"properties":248},{"id":35,"name":36},[53],{},[],{"id":250,"direction":23,"blocks":251},"uc696",[252,268,280],{"id":253,"type":27,"text":254,"paragraphStyle":255,"runs":258},"uc696:p0001","Obtaining ISO certifications: ISO 14001 for Environmental Management Systems, and ISO 13485 and 9001 for Quality Management Systems.\n",{"id":256,"name":257},"ParagraphStyle\u002Fmain text with bullets","main text with bullets",[259],{"character_style":260,"text":254,"token_types":261,"overrides":262,"properties":264},{"id":35,"name":36},[39,53],{"FontStyle":263},"Regular",[265],{"tag":160,"attributes":266,"text":267},{"type":162},"Gotham",{"id":269,"type":27,"text":270,"paragraphStyle":271,"runs":272},"uc696:p0002","\n\n\n\n",{"id":256,"name":257},[273],{"character_style":274,"text":270,"token_types":275,"overrides":276,"properties":277},{"id":35,"name":36},[53,53,53,53],{"FontStyle":263},[278],{"tag":160,"attributes":279,"text":267},{"type":162},{"id":281,"type":27,"text":282,"paragraphStyle":283,"runs":284},"uc696:p0003","Adhering to Good Manufacturing Practices (GMP) to ensure safe and effective production.\nTransitioning from diesel generators to Saudi electrical power, contributing to reduced environmental impact.\nImplementing water and energy conservation strategies, along with safe disposal and recycling of medical products, and establishing emission monitoring and reduction procedures to ensure environmental compliance and achieve sustainability goals.\n",{"id":256,"name":257},[285],{"character_style":286,"text":282,"token_types":287,"overrides":288,"properties":289},{"id":35,"name":36},[39,53,39,53,39,53],{"FontStyle":263},[290],{"tag":160,"attributes":291,"text":267},{"type":162},{"id":293,"direction":23,"blocks":294},"ua58f",[295],{"id":296,"type":27,"text":297,"paragraphStyle":298,"runs":299},"ua58f:p0001","Certification\nISO 14001",{"id":78,"name":79},[300,312],{"character_style":301,"text":302,"token_types":303,"overrides":304,"properties":306},{"id":35,"name":36},"Certification",[39],{"FontStyle":41,"PointSize":305},"14",[307,310],{"tag":45,"attributes":308,"text":309},{"type":69},"24",{"tag":160,"attributes":311,"text":163},{"type":162},{"character_style":313,"text":314,"token_types":315,"overrides":316,"properties":317},{"id":35,"name":36},"\nISO 14001",[53,39],{"FontStyle":41,"PointSize":309},[318,320],{"tag":45,"attributes":319,"text":309},{"type":69},{"tag":160,"attributes":321,"text":163},{"type":162},{"id":323,"direction":23,"blocks":324},"ua5c7",[325],{"id":326,"type":27,"text":327,"paragraphStyle":328,"runs":329},"ua5c7:p0001","Certification\nISO 13485",{"id":78,"name":79},[330,339,349],{"character_style":331,"text":302,"token_types":332,"overrides":333,"properties":334},{"id":35,"name":36},[39],{"FontStyle":41,"PointSize":305},[335,337],{"tag":45,"attributes":336,"text":309},{"type":69},{"tag":160,"attributes":338,"text":163},{"type":162},{"character_style":340,"text":341,"token_types":342,"overrides":343,"properties":344},{"id":35,"name":36},"\nISO ",[53,39],{"FontStyle":41,"PointSize":309},[345,347],{"tag":45,"attributes":346,"text":309},{"type":69},{"tag":160,"attributes":348,"text":163},{"type":162},{"character_style":350,"text":351,"token_types":352,"overrides":353,"properties":354},{"id":35,"name":36},"13485",[39],{"FontStyle":41,"PointSize":309},[355],{"tag":160,"attributes":356,"text":163},{"type":162},{"id":358,"direction":23,"blocks":359},"ua5de",[360],{"id":361,"type":27,"text":362,"paragraphStyle":363,"runs":364},"ua5de:p0001","Certification\nISO 9001",{"id":78,"name":79},[365,374,383],{"character_style":366,"text":302,"token_types":367,"overrides":368,"properties":369},{"id":35,"name":36},[39],{"FontStyle":41,"PointSize":305},[370,372],{"tag":45,"attributes":371,"text":309},{"type":69},{"tag":160,"attributes":373,"text":163},{"type":162},{"character_style":375,"text":341,"token_types":376,"overrides":377,"properties":378},{"id":35,"name":36},[53,39],{"FontStyle":41,"PointSize":309},[379,381],{"tag":45,"attributes":380,"text":309},{"type":69},{"tag":160,"attributes":382,"text":163},{"type":162},{"character_style":384,"text":385,"token_types":386,"overrides":387,"properties":388},{"id":35,"name":36},"9001",[39],{"FontStyle":41,"PointSize":309},[389],{"tag":160,"attributes":390,"text":163},{"type":162},{"id":392,"direction":23,"blocks":393},"uc65f",[394,412,424,442,454,466,485,497,515,527,545,557,575],{"id":395,"type":27,"text":396,"paragraphStyle":397,"runs":398},"uc65f:p0001","Expertise in Private Label Manufacturing\n",{"id":30,"name":31},[399,407],{"character_style":400,"text":401,"token_types":402,"overrides":403,"properties":404},{"id":35,"name":36},"Expertise in Private Label Manufacturing",[39],{"FontStyle":41,"PointSize":42},[405],{"tag":45,"attributes":406,"text":48},{"type":47},{"character_style":408,"text":51,"token_types":409,"overrides":410,"properties":411},{"id":35,"name":36},[53],{},[],{"id":413,"type":27,"text":414,"paragraphStyle":415,"runs":416},"uc65f:p0002","As a trusted private label manufacturer, Avalon Pharma collaborates with its clients to deliver high-quality products tailored to their specific requirements. Rigorous testing, approval, and validation processes ensure that these products comply with the highest safety and quality standards.\n",{"id":59,"name":60},[417],{"character_style":418,"text":414,"token_types":419,"overrides":420,"properties":421},{"id":35,"name":36},[39,53],{},[422],{"tag":45,"attributes":423,"text":70},{"type":69},{"id":425,"type":27,"text":426,"paragraphStyle":427,"runs":428},"uc65f:p0003","Advancing Through Research and Development\n",{"id":30,"name":31},[429,437],{"character_style":430,"text":431,"token_types":432,"overrides":433,"properties":434},{"id":35,"name":36},"Advancing Through Research and Development",[39],{"FontStyle":41,"PointSize":42},[435],{"tag":45,"attributes":436,"text":48},{"type":47},{"character_style":438,"text":51,"token_types":439,"overrides":440,"properties":441},{"id":35,"name":36},[53],{},[],{"id":443,"type":27,"text":444,"paragraphStyle":445,"runs":446},"uc65f:p0004","Innovation is the driving force behind Avalon’s manufacturing success, with the R&D center fostering a culture of exploration and innovation, and supporting product development through advanced analytical expertise and technologies. This focus on continuous improvement reinforces Avalon Pharma’s position as a leader in healthcare manufacturing.\n",{"id":59,"name":60},[447],{"character_style":448,"text":444,"token_types":449,"overrides":450,"properties":451},{"id":35,"name":36},[39,53],{},[452],{"tag":45,"attributes":453,"text":70},{"type":69},{"id":455,"type":27,"text":456,"paragraphStyle":457,"runs":458},"uc65f:p0005","Avalon’s manufacturing excellence not only ensures a stable supply of high-quality products but also underscores its commitment to innovation, sustainability, and meeting the needs of its regional markets.\n",{"id":59,"name":60},[459],{"character_style":460,"text":456,"token_types":461,"overrides":462,"properties":463},{"id":35,"name":36},[39,53],{},[464],{"tag":45,"attributes":465,"text":70},{"type":69},{"id":467,"type":27,"text":468,"paragraphStyle":469,"runs":472},"uc65f:p0006","03 Business Development\n",{"id":470,"name":471},"ParagraphStyle\u002Fheader%3ahaidline main text فرعي 1","header:haidline main text فرعي 1",[473,480],{"character_style":474,"text":16,"token_types":475,"overrides":476,"properties":477},{"id":35,"name":36},[39],{},[478],{"tag":45,"attributes":479,"text":70},{"type":69},{"character_style":481,"text":51,"token_types":482,"overrides":483,"properties":484},{"id":35,"name":36},[53],{},[],{"id":486,"type":27,"text":487,"paragraphStyle":488,"runs":489},"uc65f:p0007","Avalon’s business development initiatives are a key driver of its strategic growth and sustainable success. Through innovative partnerships, licensing opportunities both locally and internationally, and a flexible market expansion approach, Avalon continues to strengthen its leadership in the pharmaceutical and healthcare sector.\n",{"id":59,"name":60},[490],{"character_style":491,"text":487,"token_types":492,"overrides":493,"properties":494},{"id":35,"name":36},[39,53],{},[495],{"tag":45,"attributes":496,"text":70},{"type":69},{"id":498,"type":27,"text":499,"paragraphStyle":500,"runs":501},"uc65f:p0008","Portfolio Expansion Agreements\n",{"id":30,"name":31},[502,510],{"character_style":503,"text":504,"token_types":505,"overrides":506,"properties":507},{"id":35,"name":36},"Portfolio Expansion Agreements",[39],{"FontStyle":41,"PointSize":42},[508],{"tag":45,"attributes":509,"text":48},{"type":47},{"character_style":511,"text":51,"token_types":512,"overrides":513,"properties":514},{"id":35,"name":36},[53],{},[],{"id":516,"type":27,"text":517,"paragraphStyle":518,"runs":519},"uc65f:p0009","The company leverages these agreements to access the latest technologies and expand its product range. Through collaboration with global partners, Avalon integrates advanced technological processes into its modern manufacturing facilities. This approach enables the company to deliver innovative products that address diverse therapeutic needs, strengthening its competitive capabilities.\n",{"id":59,"name":60},[520],{"character_style":521,"text":517,"token_types":522,"overrides":523,"properties":524},{"id":35,"name":36},[39,53],{},[525],{"tag":45,"attributes":526,"text":70},{"type":69},{"id":528,"type":27,"text":529,"paragraphStyle":530,"runs":531},"uc65f:p0010","Licensing Rights of Avalon’s Trusted Products to External Partners\n",{"id":30,"name":31},[532,540],{"character_style":533,"text":534,"token_types":535,"overrides":536,"properties":537},{"id":35,"name":36},"Licensing Rights of Avalon’s Trusted Products to External Partners",[39],{"FontStyle":41,"PointSize":42},[538],{"tag":45,"attributes":539,"text":48},{"type":47},{"character_style":541,"text":51,"token_types":542,"overrides":543,"properties":544},{"id":35,"name":36},[53],{},[],{"id":546,"type":27,"text":547,"paragraphStyle":548,"runs":549},"uc65f:p0011","Avalon’s strong pharmaceutical formulations attract companies seeking to reduce risk and accelerate market entry, leveraging its expertise in manufacturing and regulatory affairs. Avalon supports its partners in efficiently launching its trusted products into new markets.\nAdditionally, the production of selected products under private label arrangements contributes to partners’ growth, while ensuring the highest standards of quality and safety.\n",{"id":59,"name":60},[550],{"character_style":551,"text":547,"token_types":552,"overrides":553,"properties":554},{"id":35,"name":36},[39,53,39,53],{},[555],{"tag":45,"attributes":556,"text":70},{"type":69},{"id":558,"type":27,"text":559,"paragraphStyle":560,"runs":561},"uc65f:p0012","Excellence in Contract Manufacturing\n",{"id":30,"name":31},[562,570],{"character_style":563,"text":564,"token_types":565,"overrides":566,"properties":567},{"id":35,"name":36},"Excellence in Contract Manufacturing",[39],{"FontStyle":41,"PointSize":42},[568],{"tag":45,"attributes":569,"text":48},{"type":47},{"character_style":571,"text":51,"token_types":572,"overrides":573,"properties":574},{"id":35,"name":36},[53],{},[],{"id":576,"type":27,"text":577,"paragraphStyle":578,"runs":579},"uc65f:p0013","Avalon has expanded its manufacturing capabilities to become a trusted partner in contract manufacturing (production under formal agreements). Through its flexible and scalable production capacity, the company provides solutions for both pilot-scale production and large-scale commercial manufacturing.\nIn addition, Avalon collaborates with other contract manufacturers to meet demand for products beyond its existing production lines, ensuring that all partnerships align with its strict quality and compliance standards.\n",{"id":59,"name":60},[580],{"character_style":581,"text":577,"token_types":582,"overrides":583,"properties":584},{"id":35,"name":36},[39,53,39,53],{},[585],{"tag":45,"attributes":586,"text":70},{"type":69},{"id":588,"direction":23,"blocks":589},"uc635",[590,608,618,636],{"id":591,"type":27,"text":592,"paragraphStyle":593,"runs":594},"uc635:p0001","Strategic Alliances for Long-Term Growth\n",{"id":30,"name":31},[595,603],{"character_style":596,"text":597,"token_types":598,"overrides":599,"properties":600},{"id":35,"name":36},"Strategic Alliances for Long-Term Growth",[39],{"FontStyle":41,"PointSize":42},[601],{"tag":45,"attributes":602,"text":48},{"type":47},{"character_style":604,"text":51,"token_types":605,"overrides":606,"properties":607},{"id":35,"name":36},[53],{},[],{"id":609,"type":27,"text":610,"paragraphStyle":611,"runs":612},"uc635:p0002","Avalon’s collaborative and integrated business approach reflects its commitment to building strategic alliances that drive growth. The company actively pursues long-term partnerships founded on mutual trust, transparency, and shared objectives. By integrating resources and strengthening relationships based on mutual interests, Avalon creates sustainable value for its partners, fostering innovation and enhancing its competitiveness at both local and global levels.\nDuring the year, Avalon successfully completed the development and SFDA registration procedures for 12 new products, supporting the expansion of its growth pipeline. In parallel, the company entered into an agreement to develop and commercialize a generic version of (Wegovy) an anti-obesity product within the GLP-1 class of medications—expanding its presence in advanced obesity treatments.\nAdditionally, Avalon finalized two agreements in the oncology segment, reinforcing the expansion of its specialized product portfolio. The Business Development team continued collaborating with approved development partners to advance oncology products and complex injectable formulations, while also focusing on selected opportunities in the aesthetics segment, including microneedling technology .\n",{"id":59,"name":60},[613],{"character_style":614,"text":610,"token_types":615,"overrides":616,"properties":617},{"id":35,"name":36},[39,53,39,53,39,53],{},[],{"id":619,"type":27,"text":620,"paragraphStyle":621,"runs":622},"uc635:p0003","A Structured Partnership Approach\n",{"id":30,"name":31},[623,631],{"character_style":624,"text":625,"token_types":626,"overrides":627,"properties":628},{"id":35,"name":36},"A Structured Partnership Approach",[39],{"FontStyle":41,"PointSize":42},[629],{"tag":45,"attributes":630,"text":48},{"type":47},{"character_style":632,"text":51,"token_types":633,"overrides":634,"properties":635},{"id":35,"name":36},[53],{},[],{"id":637,"type":27,"text":638,"paragraphStyle":639,"runs":640},"uc635:p0004","Avalon’s partnership strategy is designed to ensure effective and value-driven collaboration:\n",{"id":59,"name":60},[641],{"character_style":642,"text":638,"token_types":643,"overrides":644,"properties":645},{"id":35,"name":36},[39,53],{},[],{"id":647,"direction":23,"blocks":648},"uc604",[649],{"id":650,"type":27,"text":651,"paragraphStyle":652,"runs":655},"uc604:p0001","Selection\nConducting a thorough evaluation of potential partners to ensure alignment with Avalon’s values and strategic objectives.\n",{"id":653,"name":654},"ParagraphStyle\u002Fmain text w","main text w",[656,665,670],{"character_style":657,"text":658,"token_types":659,"overrides":660,"properties":664},{"id":35,"name":36},"Selection",[39],{"AppliedLanguage":661,"FontStyle":662,"PointSize":663},"$ID\u002FEnglish: USA","Black","18",[],{"character_style":666,"text":51,"token_types":667,"overrides":668,"properties":669},{"id":35,"name":36},[53],{"AppliedLanguage":661},[],{"character_style":671,"text":672,"token_types":673,"overrides":674,"properties":675},{"id":35,"name":36},"Conducting a thorough evaluation of potential partners to ensure alignment with Avalon’s values and strategic objectives.\n",[39,53],{"AppliedLanguage":661},[676],{"tag":45,"attributes":677,"text":48},{"type":47},{"id":679,"direction":23,"blocks":680},"uc61d",[681],{"id":682,"type":27,"text":683,"paragraphStyle":684,"runs":685},"uc61d:p0001","Search\nConducting in-depth analytical studies to select partners with complementary expertise and aligned strategic objectives.\n",{"id":653,"name":654},[686,694,699],{"character_style":687,"text":688,"token_types":689,"overrides":690,"properties":691},{"id":35,"name":36},"Search",[39],{"AppliedLanguage":661,"FontStyle":41,"PointSize":663},[692],{"tag":160,"attributes":693,"text":267},{"type":162},{"character_style":695,"text":51,"token_types":696,"overrides":697,"properties":698},{"id":35,"name":36},[53],{"AppliedLanguage":661},[],{"character_style":700,"text":701,"token_types":702,"overrides":703,"properties":706},{"id":35,"name":36},"Conducting in-depth analytical studies to select partners with complementary expertise and aligned strategic objectives.\n",[39,53],{"AppliedLanguage":661,"FontStyle":704,"PointSize":705},"Book","10",[707,709],{"tag":45,"attributes":708,"text":48},{"type":47},{"tag":160,"attributes":710,"text":267},{"type":162},{"id":712,"direction":23,"blocks":713},"uc5d5",[714],{"id":715,"type":27,"text":716,"paragraphStyle":717,"runs":718},"uc5d5:p0001","Assurance\nImplementing ongoing measures to maintain the integrity and effectiveness of the partnership.\n",{"id":653,"name":654},[719,727],{"character_style":720,"text":721,"token_types":722,"overrides":723,"properties":724},{"id":35,"name":36},"Assurance",[39],{"AppliedLanguage":661,"FontStyle":662,"PointSize":663},[725],{"tag":45,"attributes":726,"text":48},{"type":47},{"character_style":728,"text":729,"token_types":730,"overrides":731,"properties":732},{"id":35,"name":36},"\nImplementing ongoing measures to maintain the integrity and effectiveness of the partnership.\n",[53,39,53],{"AppliedLanguage":661},[733],{"tag":45,"attributes":734,"text":48},{"type":47},{"id":736,"direction":23,"blocks":737},"uc5ec",[738],{"id":739,"type":27,"text":740,"paragraphStyle":741,"runs":742},"uc5ec:p0001","Initiation\nLaunching collaborative initiatives with clearly defined objectives to achieve mutual growth.\n",{"id":653,"name":654},[743,751,758],{"character_style":744,"text":745,"token_types":746,"overrides":747,"properties":748},{"id":35,"name":36},"Initiation",[39],{"AppliedLanguage":661,"FontStyle":662,"PointSize":663},[749],{"tag":45,"attributes":750,"text":48},{"type":47},{"character_style":752,"text":51,"token_types":753,"overrides":754,"properties":755},{"id":35,"name":36},[53],{},[756],{"tag":45,"attributes":757,"text":48},{"type":47},{"character_style":759,"text":760,"token_types":761,"overrides":762,"properties":763},{"id":35,"name":36},"Launching collaborative initiatives with clearly defined objectives to achieve mutual growth.\n",[39,53],{"AppliedLanguage":661},[764],{"tag":45,"attributes":765,"text":48},{"type":47},{"id":767,"direction":23,"blocks":768},"uc5b9",[769,787,807,821,845,858],{"id":770,"type":27,"text":771,"paragraphStyle":772,"runs":773},"uc5b9:p0001","Growth Vision\n",{"id":30,"name":31},[774,782],{"character_style":775,"text":776,"token_types":777,"overrides":778,"properties":779},{"id":35,"name":36},"Growth Vision",[39],{"FontStyle":41,"PointSize":42},[780],{"tag":45,"attributes":781,"text":48},{"type":47},{"character_style":783,"text":51,"token_types":784,"overrides":785,"properties":786},{"id":35,"name":36},[53],{},[],{"id":788,"type":27,"text":789,"paragraphStyle":790,"runs":791},"uc5b9:p0002","Avalon’s business development efforts align with its “ACE” strategy Accelerate, Catalyze ,Expand.\nThese initiatives include:\n\n",{"id":59,"name":60},[792,799],{"character_style":793,"text":794,"token_types":795,"overrides":796,"properties":798},{"id":35,"name":36},"Avalon’s business development efforts align with its “ACE” strategy Accelerate, Catalyze ,Expand.\nThese initiatives include:\n",[39,53,39,53],{"Tracking":797},"-10",[],{"character_style":800,"text":51,"token_types":801,"overrides":802,"properties":803},{"id":35,"name":36},[53],{"Tracking":797},[804],{"tag":45,"attributes":805,"text":806},{"type":69},"7",{"id":808,"type":27,"text":809,"paragraphStyle":810,"runs":811},"uc5b9:p0003","Expanding market reach through strategic alliances and innovative licensing agreements.\n",{"id":256,"name":257},[812],{"character_style":813,"text":809,"token_types":814,"overrides":815,"properties":816},{"id":35,"name":36},[39,53],{},[817,819],{"tag":45,"attributes":818,"text":48},{"type":47},{"tag":160,"attributes":820,"text":267},{"type":162},{"id":822,"type":27,"text":823,"paragraphStyle":824,"runs":825},"uc5b9:p0004","Enhancing manufacturing capabilities to meet the growing demand in the global healthcare sector.\nMaintaining Avalon’s position as a leading player in key therapeutic categories.\n",{"id":256,"name":257},[826,836],{"character_style":827,"text":828,"token_types":829,"overrides":830,"properties":831},{"id":35,"name":36},"Enhancing manufacturing capabilities to meet the growing demand in the global healthcare sector.\nMaintaining Avalon’s position as a leading player in key therapeutic categories.",[39,53,39],{},[832,834],{"tag":45,"attributes":833,"text":48},{"type":47},{"tag":160,"attributes":835,"text":267},{"type":162},{"character_style":837,"text":51,"token_types":838,"overrides":839,"properties":840},{"id":35,"name":36},[53],{"FontStyle":263},[841,843],{"tag":45,"attributes":842,"text":86},{"type":69},{"tag":160,"attributes":844,"text":267},{"type":162},{"id":846,"type":27,"text":51,"paragraphStyle":847,"runs":848},"uc5b9:p0005",{"id":256,"name":257},[849],{"character_style":850,"text":51,"token_types":851,"overrides":852,"properties":853},{"id":35,"name":36},[53],{"FontStyle":263},[854,856],{"tag":45,"attributes":855,"text":86},{"type":69},{"tag":160,"attributes":857,"text":267},{"type":162},{"id":859,"type":27,"text":860,"paragraphStyle":861,"runs":862},"uc5b9:p0006","Through its dynamic and forward-looking approach, Avalon continues to set new standards in delivering innovative healthcare solutions, while ensuring sustainable growth for its partners and stakeholders.",{"id":59,"name":60},[863,871],{"character_style":864,"text":865,"token_types":866,"overrides":867,"properties":868},{"id":35,"name":36},"Through its dynamic and forward-looking approach, Avalon continues to set new standards in delivering innovative healthcare solutions, while ensuring sustainable growth for its partners and ",[39],{},[869],{"tag":45,"attributes":870,"text":48},{"type":47},{"character_style":872,"text":873,"token_types":874,"overrides":875,"properties":876},{"id":35,"name":36},"stakeholders.",[39],{},[877],{"tag":45,"attributes":878,"text":70},{"type":69},{"id":880,"direction":23,"blocks":881},"uc587",[882,895,913,925,943,957,968],{"id":883,"type":27,"text":51,"paragraphStyle":884,"runs":887},"uc587:p0001",{"id":885,"name":886},"ParagraphStyle\u002Fheader%3amain text med blue copy","header:main text med blue copy",[888],{"character_style":889,"text":51,"token_types":890,"overrides":891,"properties":892},{"id":35,"name":36},[53],{},[893],{"tag":45,"attributes":894,"text":70},{"type":69},{"id":896,"type":27,"text":897,"paragraphStyle":898,"runs":899},"uc587:p0002","Operational Performance Assessment\n",{"id":30,"name":31},[900,908],{"character_style":901,"text":902,"token_types":903,"overrides":904,"properties":905},{"id":35,"name":36},"Operational Performance Assessment",[39],{"FontStyle":41,"PointSize":42},[906],{"tag":45,"attributes":907,"text":48},{"type":47},{"character_style":909,"text":51,"token_types":910,"overrides":911,"properties":912},{"id":35,"name":36},[53],{},[],{"id":914,"type":27,"text":915,"paragraphStyle":916,"runs":917},"uc587:p0003","In 2025, Avalon’s business development efforts played a pivotal role in executing its strategic roadmap, aligned with its ambitious ACE framework (Accelerate, Catalyze, Expand). The focus was on innovation, expanding strategic alliances, and entering new markets.\n",{"id":59,"name":60},[918],{"character_style":919,"text":915,"token_types":920,"overrides":921,"properties":922},{"id":35,"name":36},[39,53],{},[923],{"tag":45,"attributes":924,"text":48},{"type":47},{"id":926,"type":27,"text":927,"paragraphStyle":928,"runs":929},"uc587:p0004","Key achievements include:\n",{"id":30,"name":31},[930,938],{"character_style":931,"text":932,"token_types":933,"overrides":934,"properties":935},{"id":35,"name":36},"Key achievements include:",[39],{"FontStyle":41,"PointSize":42},[936],{"tag":45,"attributes":937,"text":48},{"type":47},{"character_style":939,"text":51,"token_types":940,"overrides":941,"properties":942},{"id":35,"name":36},[53],{},[],{"id":944,"type":27,"text":945,"paragraphStyle":946,"runs":949},"uc587:p0005","Strengthening Strategic Alliances and External Licensing Agreements: Avalon expanded its collaboration with leading retailers, transitioning from a supplier role to a manufacturer. This enabled the production of private label products and strengthened Avalon’s market presence. These partnerships reinforced Avalon’s position in the Saudi market, demonstrating its ability to deliver specialized solutions that effectively meet customer needs.\nMarket Expansion: The company achieved significant growth in export markets, with successful relaunches in Kuwait and the UAE. These initiatives helped establish Avalon as a regional leader, leveraging support from the Saudi Export Development Authority to access new markets.\nInnovation-Driven Product Line: Avalon’s R&D efforts produced advanced products supported by strategic technology transfer agreements. These partnerships aim to localize advanced pharmaceutical technologies and strengthen Avalon’s presence in specialized sectors such as oncology and ophthalmology treatments.\n",{"id":947,"name":948},"ParagraphStyle\u002Fmain text with bullets number","main text with bullets number",[950],{"character_style":951,"text":945,"token_types":952,"overrides":953,"properties":954},{"id":35,"name":36},[39,53,39,53,39,53],{},[955],{"tag":45,"attributes":956,"text":70},{"type":69},{"id":958,"type":27,"text":51,"paragraphStyle":959,"runs":960},"uc587:p0006",{"id":947,"name":948},[961],{"character_style":962,"text":51,"token_types":963,"overrides":964,"properties":965},{"id":35,"name":36},[53],{},[966],{"tag":45,"attributes":967,"text":70},{"type":69},{"id":969,"type":27,"text":970,"paragraphStyle":971,"runs":972},"uc587:p0007","Looking ahead, Avalon’s Business Development team is preparing to build on these achievements by focusing on exclusive product launches, expanding regional partnerships, and aligning with Saudi Vision 2030 objectives. This includes strengthening collaborations with local content supporters to localize production and exploring high-value therapeutic sectors to meet the growing demand for healthcare services.\n",{"id":59,"name":60},[973,981],{"character_style":974,"text":975,"token_types":976,"overrides":977,"properties":978},{"id":35,"name":36},"Looking ahead, Avalon’s Business Development team is preparing to build on these achievements by focusing on exclusive product launches, expanding regional partnerships, and aligning with Saudi Vision 2030 objectives. This includes strengthening collaborations with local content supporters to localize production and exploring high-value therapeutic sectors to meet the growing demand for healthcare services.",[39],{},[979],{"tag":45,"attributes":980,"text":48},{"type":47},{"character_style":982,"text":51,"token_types":983,"overrides":984,"properties":986},{"id":35,"name":36},[53],{"ParagraphBreakType":985},"NextPage",[987],{"tag":45,"attributes":988,"text":48},{"type":47},1790446649797]